Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Clinical trial NCT06541262 · RECRUITING

Trial details

NCT number: NCT06541262
Sponsor: Milton S. Hershey Medical Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neuroblastoma Ewing Sarcoma Osteosarcoma Rhabdomyosarcoma Liposarcoma

Start date: 2024-10-30
Primary completion: 2030-11-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.